Selective inactivation of p27Kip1 in hematopoietic progenitor cells increases neointimal macrophage proliferation and accelerates atherosclerosis

Blood

Volumn 103, Issue 1, 2004, Pages 158-161

  Díez Juan, Antonio ^b   Pérez, Paloma ^b   Aracil, Miguel ^b   Sancho, David ^b   Bernad, Antonio ^b   Sánchez Madrid, Francisco ^b   Andrés, Vicente ^a  

^a INSTITUTO DE BIOMEDICINA DE VALENCIA   (Spain)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; CYCLINE; CYTOKINE; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEIN P27; RANTES;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; ATHEROSCLEROSIS; BONE MARROW TRANSPLANTATION; CELL PROLIFERATION; CHOLESTEROL DIET; DISEASE EXACERBATION; FEMALE; GENE DISRUPTION; HEMATOPOIETIC STEM CELL; IMMUNOCOMPETENT CELL; INFLAMMATION; INTIMA; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; VASCULAR SMOOTH MUSCLE;

EID: 0346336788     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2003-07-2319     Document Type: Article

References (27)

1. Lusis AJ. Atherosclerosis. Nature. 2000;407:233-241.
2. Binder CJ, Chang MK, Shaw PX, et al. Innate and acquired immunity in atherogenesis. Nat Med. 2002;8:1218-1226.
3. Kip1/cyclin-dependent kinase/retinoblastoma pathway in vascular smooth muscle cells and fibroblasts. Circ Res. 2003;92:402-410.
4. Tanner FC, Yang Z-Y, Duckers E, Gordon D, Nabel GJ, Nabel EG. Expression of cyclin-dependent kinase inhibitors in vascular disease. Circ Res. 1998;82:396-403.
5. Kip1 and cyclin E in human atherosclerotic tissue: implications for lesion cellularity. Atherosclerosis. 1999;144:7-14.
6. Kip1 protects against diet-induced atherosclerosis. FASEB J. 2001;15:1989-1995.
7. Kip1-deficient mice. Cell. 1996;85:733-744.
8. Linton MF, Atkinson JB, Fazio S. Prevention of atherosclerosis in apolipoprotein E-deficient mice by bone marrow transplantation. Science. 1995;267:1034-1037.
9. kip1. Nat Med. 2000;6:1235-1240.
10. Bravo R. Synthesis of the nuclear protein (PCNA) and its relationships with DNA replication. Exp Cell Res. 1986;163:287-293.
11. Hall P, Levison D, Woods A, et al. Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: an index of cell proliferation with evidence of deregulated expression in some neoplasms. J Pathol. 1990;162:285-294.
12. Hall PA, Woods AL. Immunohistochemical markers of cell proliferation: achievements, problems and prospects. Cell Tiss Kinet. 1990;23:502-522.
13. Kip1 regulatory checkpoint. J Clin Invest. 1997;99:2867-2876.
14. Waf1. Blood. 2001;98:2124-2133.
15. Guevara NV, Kim HS, Antonova El, Chan L. The absence of p53 accelerates atherosclerosis by increasing cell proliferation in vivo. Nat Med. 1999;5:335-339.
16. van Vlijmen BJ, Gerritsen G, Franken AL, et al. Macrophage p53 deficiency leads to enhanced atherosclerosis in APOE*3-Leiden transgenic mice. Circ Res. 2001;88:780-786.
17. Merched AJ, Williams E, Chan L. Macrophage-specific p53 expression plays a crucial role in atherosclerosis development and plaque remodeling. Arterioscler Thromb Vasc Biol. 2003;23:1608-1614.
18. Peters W, Charo IF. Involvement of chemokine receptor 2 and its ligand, monocyte chemoattractant protein-1, in the development of atherosclerosis: lessons from knockout mice. Curr Opin Lipidol. 2001;12:175-180.
19. van Royen N, Hoefer I, Bottinger M, et al. Local monocyte chemoattractant protein-1 therapy increases collateral artery formation in apolipoprotein E-deficient mice but induces systemic monocytic CD11b expression, neointimal formation, and plaque progression. Circ Res. 2003;92:218-225.
20. von Hundelshausen P, Weber KS, Huo Y, et al. RANTES deposition by platelets triggers monocyte arrest on inflamed and atherosclerotic endothelium. Circulation. 2001;103:1772-1777.
21. Kip1, expression is required for development and function of T cells. J Immunol. 2001;166:304-312.
22. Kip1. J Immunol. 2000;165:6270-6277.
23. Kip1. J Immunol. 2002;169:714-721.
24. Mohapatra S, Agrawal D, Pledger WJ. p27Kip1 regulates T cell proliferation. J Biol Chem. 2001;276:21976-21983.
25. Laliberte J, Yee A, Xiong Y, Mitchell BS. Effects of guanine nucleotide depletion on cell cycle progression in human T lymphocytes. Blood. 1998;91:2896-2904.
26. Kip1 in chronic B-cell lymphocytic leukemia. Blood. 1998;91:4694-4700.
27. Chiarle R, Budel LM, Skolnik J, et al. Increased proteasome degradation of cyclin-dependent kinase inhibitor p27 is associated with a decreased overall survival in mantle cell lymphoma. Blood. 2000;95:619-626.